May 28, 2020
16 May 2020 the Russian Government enacted the rules on online sales and delivery of medicines (the Rules). According to the Rules, online sales of medicines are allowed. The exceptions are: RX medicines, narcotic and psychotropic medicines, and medicines containing more than 25% ethyl alcohol.
To receive authorization for online sales a pharmacy shall have a license for at least 1 year, minimum of 10 retail stores, an Internet website or a mobile app, a delivery service, or a contract with such service provider.
November 28, 2018
On 24 April 2018 the Intellectual Property Court published its Decision in case A41 85807/2016 between Swiss-based Novartis AG and local generic Nativa LLC.
ILN Today Post
August 16, 2018
Washington, DC (August 16, 2018) – Epstein Becker Green (EBG) is pleased to announce that Neil P. Di Spirito, an attorney with more than two decades of experience advising pharmaceutical, medical device, biologic, and life sciences clients on compliance with U.S. Food and Drug Administration (FDA) regulations, has joined as a Member of the Firm in the Health Care and Life Sciences practice in the District of Columbia and Florida.
March 1, 2018
Reflected by the Pravo.ru’s Sympathy Rating – 2017 identifying the most prominent legal advisors in Russia based on the feedback of peers Lidings recognized as a leading firm for its expertise in employment law and pharmaceuticals and healthcare industry practice area. Individual and moreover exclusive recognition as the only recommended lawyer in this sphere, for a remarkable work for advising pharmaceutical companies in Russia, is given to Lidings’ Managing Partner, Head of the firm’s Pharmaceuticals and Healthcare industry practice, Andrey Zelenin.
ILN Today Post
April 30, 2013
The Russian pharmaceutical market has been extensively developing over the past decade, largely influenced by foreign investments in this area of the country’s economy. It is currently one of the top 10 largest pharmaceutical markets in the world. At the same time, the Russian pharma market has witnessed stricter state regulation of pharmaceutical activity, generally defined as a certain restraining measure over uncontrolled pharma market growth. The escalation of state control within the industry is especially noticeable during the past two years. More…
March 24, 2013
Lidings law firm, the leading legal advisor to foreign businesses in the Russian market, further strengthens its Pharmaceutical practice with the addition of key international clients, leaders in their field.
With Life Sciences being one of Lidings’ most rapidly developing practice areas the firm’s client list boasts industry leaders including pharmaceutical giants like Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, MEDA Pharmaceuticals, Sanofi Aventis, Servier, and others.
ILN Today Post
February 12, 2013
The bill “On amendments to the Federal Law “On circulation of drugs” and to the article 333.32.1. of the second part of the Tax Code of the Russian Federation” (hereinafter referred to as the “Bill”) has been published on the web-site of the Ministry of Healthcare of the Russian Federation.
The Bill offers a number of major changes to the Federal Law # 61- FZ “On circulation of drugs” dated 12th of April 2010 (hereinafter referred to as the “Law- # 61-FZ”) primarily concerning the registration of new drug products. Thus, the Bill amends inter alia the article 4 of the Law- # 61-FZ by clarifying certain existing definitions (for instance, “generic drug”) as well as introducing the new ones: “comparison drug”, “biosimilar product”, “substitutable drug”. More…
December 1, 2011
By: David Garland and Douglas Weiner
In February 2011, the U.S. Court of Appeals for the Ninth Circuit gave a resounding victory to employers in the pharmaceutical industry by finding that pharmaceutical sales representatives are covered by the outside sales exemption of the Fair Labor Standards Act (“FLSA”). Christopher v. SmithKline Beecham, No. 10-15257 (9th Cir. Feb. 14, 2011). Plaintiffs, and the U.S. Department of Labor (“DOL”) in an amicus brief, had argued the exemption did not apply because sales reps are prohibited from making the final sale. Prescription medicine in the heavily regulated pharmaceutical industry can only be sold to the ultimate consumer with the authorization of a licensed physician. Sales reps use their “selling skills” to persuade doctors to prescribe their employer’s products when the doctor’s patients have a medical need for them. Sales reps do not transfer title to the medicine themselves.